Syndecan-4 Regulates Subcellular Localization of mTOR Complex2 and Akt Activation in a PKCα-Dependent Manner in Endothelial Cells

Molecular Cell

Volumn 32, Issue 1, 2008, Pages 140-149

  Partovian, Chohreh ^a   Ju, Rong ^a   Zhuang, Zhen W ^a   Martin, Kathleen A ^a   Simons, Michael ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

SIGNALING

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PROTEIN KINASE B; PROTEIN KINASE C ALPHA; SYNDECAN 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTERIAL PRESSURE; ARTICLE; CELL LYSATE; CELL MEMBRANE; CELL SIZE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; KNOCKOUT MOUSE; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN TARGETING;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GROWTH SUBSTANCES; MEMBRANE MICRODOMAINS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; PROTEIN KINASE C-ALPHA; PROTO-ONCOGENE PROTEINS C-AKT; SYNDECAN-4; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

MAMMALIA; MUS;

EID: 53149083731     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2008.09.010     Document Type: Article

References (32)

1. Allport J.R., Lim Y.C., Shipley J.M., Senior R.M., Shapiro S.D., Matsuyoshi N., Vestweber D., and Luscinskas F.W. Neutrophils from MMP-9- or neutrophil elastase-deficient mice show no defect in transendothelial migration under flow in vitro. J. Leukoc. Biol. 71 (2002) 821-828
2. Balconi G., Spagnuolo R., and Dejana E. Development of endothelial cell lines from embryonic stem cells: A tool for studying genetically manipulated endothelial cells in vitro. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1443-1451
3. Beierwaltes W.H., Potter D.L., and Shesely E.G. Renal baroreceptor-stimulated renin in the eNOS knockout mouse. Am. J. Physiol. Renal Physiol. 282 (2002) F59-F64
4. Echtermeyer F., Streit M., Wilcox-Adelman S., Saoncella S., Denhez F., Detmar M., and Goetinck P. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J. Clin. Invest. 107 (2001) R9-R14
5. Fingar D.C., Salama S., Tsou C., Harlow E., and Blenis J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16 (2002) 1472-1487
6. Guertin D.A., Stevens D.M., Thoreen C.C., Burds A.A., Kalaany N.Y., Moffat J., Brown M., Fitzgerald K.J., and Sabatini D.M. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev. Cell 11 (2006) 859-871
7. Hill M.M., Feng J., and Hemmings B.A. Identification of a plasma membrane Raft-associated PKB Ser473 kinase activity that is distinct from ILK and PDK1. Curr. Biol. 12 (2002) 1251-1255
8. Hodges R.R., Raddassi I., Zoukhri D., Toker A., Kazlauskas A., and Dartt D.A. Effect of overexpression of constitutively active PKCalpha on rat lacrimal gland protein secretion. Invest. Ophthalmol. Vis. Sci. 45 (2004) 3974-3981
9. Horowitz A., and Simons M. Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase Calpha. J. Biol. Chem. 273 (1998) 25548-25551
10. Hresko R.C., and Mueckler M. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 280 (2005) 40406-40416
11. Ikenoue T., Inoki K., Yang Q., Zhou X., and Guan K.L. Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 27 (2008) 1919-1931
12. Kandel E.S., and Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res. 253 (1999) 210-229
13. Keum E., Kim Y., Kim J., Kwon S., Lim Y., Han I., and Oh E.S. Syndecan-4 regulates localization, activity and stability of protein kinase C-alpha. Biochem. J. 378 (2004) 1007-1014
14. Lang M.L., Chen Y.W., Shen L., Gao H., Lang G.A., Wade T.K., and Wade W.F. IgA Fc receptor (FcalphaR) cross-linking recruits tyrosine kinases, phosphoinositide kinases and serine/threonine kinases to glycolipid rafts. Biochem. J. 364 (2002) 517-525
15. Li W., Zhang J., Flechner L., Hyun T., Yam A., Franke T.F., and Pierce J.H. Protein kinase C-alpha overexpression stimulates Akt activity and suppresses apoptosis induced by interleukin 3 withdrawal. Oncogene 18 (1999) 6564-6572
16. Li J., Partovian C., Li J., Hampton T.G., Metais C., Tkachenko E., Sellke F.W., and Simons M. Modulation of microvascular signaling by heparan sulfate matrix: studies in syndecan-4 transgenic mice. Microvasc. Res. 64 (2002) 38-46
17. Lim S.T., Longley R.L., Couchman J.R., and Woods A. Direct binding of syndecan-4 cytoplasmic domain to the catalytic domain of protein kinase C alpha (PKC alpha) increases focal adhesion localization of PKC alpha. J. Biol. Chem. 278 (2003) 13795-13802
18. Longley R.L., Woods A., Fleetwood A., Cowling G.J., Gallagher J.T., and Couchman J.R. Control of morphology, cytoskeleton and migration by syndecan-4. J. Cell Sci. 112 (1999) 3421-3431
19. Partovian C., and Simons M. Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Calpha in endothelial cells. Cell. Signal. 16 (2004) 951-957
20. Partovian C., Zhuang Z., Moodie K., Lin M., Ouchi N., Sessa W.C., Walsh K., and Simons M. PKCalpha activates eNOS and increases arterial blood flow in vivo. Circ. Res. 97 (2005) 482-487
21. Peng X.D., Xu P.Z., Chen M.L., Hahn-Windgassen A., Skeen J., Jacobs J., Sundararajan D., Chen W.S., Crawford S.E., Coleman K.G., et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 17 (2003) 1352-1365
22. Rabinovitz I., Toker A., and Mercurio A.M. Protein kinase C-dependent mobilization of the alpha6beta4 integrin from hemidesmosomes and its association with actin-rich cell protrusions drive the chemotactic migration of carcinoma cells. J. Cell Biol. 146 (1999) 1147-1160
23. Sarbassov D.D., Guertin D.A., Ali S.M., and Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 (2005) 1098-1101
24. Shah O.J., Wang Z., and Hunter T. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr. Biol. 14 (2004) 1650-1656
25. Shiojima I., and Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90 (2002) 1243-1250
26. Simons M., and Horowitz A. Syndecan-4-mediated signalling. Cell. Signal. 13 (2001) 855-862
27. Skurk C., Izumiya Y., Maatz H., Razeghi P., Shiojima I., Sandri M., Sato K., Zeng L., Schiekofer S., Pimentel D., et al. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J. Biol. Chem. 280 (2005) 20814-20823
28. Somanath P.R., Razorenova O.V., Chen J., and Byzova T.V. Akt1 in endothelial cell and angiogenesis. Cell Cycle 5 (2006) 512-518
29. Tkachenko E., Rhodes J.M., and Simons M. Syndecans: new kids on the signaling block. Circ. Res. 96 (2005) 488-500
30. Tkachenko E., and Simons M. Clustering induces redistribution of syndecan-4 core protein into raft membrane domains. J. Biol. Chem. 277 (2002) 19946-19951
31. Yang Q., and Guan K.L. Expanding mTOR signaling. Cell Res. 17 (2007) 666-681
32. Zhang Y., Li J., Partovian C., Sellke F.W., and Simons M. Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H2078-H2082